Experts from BRG recently discussed the two presidential candidates' stances on key healthcare issues, including drug pricing ...
Many have lauded the digital transformation occurring in the healthcare sector. By modernizing its technology, the healthcare industry is moving away from inefficient methods of data exchange ...
Oshi Health, a virtual gastrointestinal center of excellence, announced Wednesday that it snagged $60 million in Series C funding, which it will use to grow and reach more patients. New York City ...
A new study published in the New England Journal of Medicine Catalyst showed that Waymark’s community-based interventions lowered hospital and emergency department visits and improved care quality.
Suki, a company offering AI voice solutions to healthcare companies, has secured $70 million in Series D funding, it announced Thursday. The financing will help the company build new products.
The past few years have seen a surge in demand for healthcare AI. This doesn’t show any signs of stopping soon — with three-quarters of the country’s providers and payers reporting that they ...
Lung cancer can be treated with small molecules formulated as pills as well as biological medications that are injected or infused, both as standalone treatments or as part of drug combinations.
Yet another Bay Area healthcare AI startup was born this week. On Tuesday, San Francisco-based generative AI voice platform Parakeet Health formally launched and announced $3 million in seed funding.
Sanofi is deepening its commitment to targeted radiation therapies for cancer with a €300 million equity investment in a new entity pursuing next-generation radioligand therapies. The new entity ...
Gilead Sciences is voluntarily withdrawing cancer drug Trodelvy from the U.S. market as a treatment for advanced cases of urothelial carcinoma, a move that comes nearly five months after the ...
HLTH 2024 at the Venetian Expo Center in Las Vegas on October 20 to 23 will spotlight a variety of startups that want to improve care coordination for providers, detect diseases earlier, improve ...
Shortly after releasing a scathing interim report in July that revealed how three players dominate the pharmacy benefit manager market and raise drug costs for patients, the Federal Trade ...